Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
J Am Acad Dermatol
.
2023 Dec;89(6):1248-1250.
doi: 10.1016/j.jaad.2023.03.041.
Epub 2023 Apr 5.
Authors
Ahmed Kazmi
1
,
Anthony Moussa
2
,
Laita Bokhari
2
,
Bevin Bhoyrul
2
,
Shobha Joseph
2
,
Vijaya Chitreddy
2
,
Samantha Eisman
2
,
Nekma Meah
3
,
Rodney Sinclair
4
Affiliations
1
Sinclair Dermatology, East Melbourne, Victoria, Australia. Electronic address:
[email protected]
.
2
Sinclair Dermatology, East Melbourne, Victoria, Australia.
3
St Helens and Knowsley Teaching Hospitals NHS Trust, Liverpool, England.
4
Sinclair Dermatology, East Melbourne, Victoria, Australia; The University of Melbourne, Melbourne, Victoria, Australia.
PMID:
37024053
DOI:
10.1016/j.jaad.2023.03.041
No abstract available
Publication types
Review
MeSH terms
Alopecia
Alopecia Areata* / drug therapy
Humans
Piperidines / therapeutic use
Substances
tofacitinib
baricitinib
Piperidines
Supplementary concepts
Diffuse alopecia